EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
E. Ohman J or Asset Management AB Buys 46,000 Shares of Bristol Myers Squibb Company $BMY
Enhanced dynamic risk stratification of smoldering multiple myeloma
Wealth Enhancement Advisory Services LLC Purchases 318,898 Shares of Bristol Myers Squibb Company $BMY
Replimune's Oncolytic Viral Therapy For Melanoma Faces Second Shot At FDA Approval
Opdivo's New cHL Approvals Reframe Bristol-Myers Squibb Growth Story
NorthCrest Asset Manangement LLC Has $24.56 Million Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
A Look At Bristol Myers Squibb (BMY) Valuation As Recent Results Shape Growth And Cost Outlook
20,156 Shares in Bristol Myers Squibb Company $BMY Purchased by MFG Wealth Management Inc. - Stock Observer
Bristol Myers Squibb Company $BMY Shares Acquired by TruWealth Advisors LLC - Daily Political
Bristol Myers Squibb Gets Expanded Opdivo Approval in U.S., Europe | Morningstar
In the U.S., FDA approval establishes Opdivo in combination
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab) | Morningstar
Union Bancaire Privee UBP SA Boosts Stake in Bristol Myers Squibb Company $BMY
Miller Global Investments LLC Invests $1.11 Million in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by Mirabella Financial Services LLP
Union Bancaire Privee UBP SA Boosts Position in Bristol Myers Squibb Company $BMY - Daily Political
20,650 Shares in Bristol Myers Squibb Company $BMY Bought by Miller Global Investments LLC - Daily Political
Bristol Myers Squibb Kidney Cancer Trial Tests Valuation And Pipeline Depth
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data
These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity
Bristol Myers Squibb Tests New Protein Degradation Cancer Drug In Humans
12,955 Shares in Bristol Myers Squibb Company $BMY Purchased by Investment Research Partners LLC - Daily Political
How Mezigdomide Trial Progress And Sotyktu Expansion At Bristol Myers Squibb (BMY) Has Changed Its Investment Story
WBI Investments LLC Has $2.70 Million Stock Holdings in Bristol Myers Squibb Company $BMY
20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style
Danske Bank A S Makes New $71.59 Million Investment in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Stake Boosted by Achmea Investment Management B.V.
Thymic health and immunotherapy outcomes in patients with cancer
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study
Thymic health consequences in adults
Bristol Myers Squibb (NYSE:BMY) Price Target Raised to $60.00
How New Oral Immunology Wins At Bristol Myers Squibb (BMY) Have Changed Its Investment Story
HSBC Issues Positive Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price - Daily Political
Bank of Nova Scotia Raises Stock Position in Bristol Myers Squibb Company $BMY
Chevy Chase Trust Holdings LLC Cuts Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily
BNP Paribas Decreases Stake in Bristol Myers Squibb Company $BMY
Chevy Chase Trust Holdings LLC Sells 35,963 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
Banco Bilbao Vizcaya Argentaria S.A. Has $29.60 Million Stock Holdings in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Acquired by Aquatic Capital Management LLC
Does Colgate-Palmolive's (CL) New Board Voice and Dividend Bump Hint at a Shifting Capital Play? - Simply Wall St News
Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference
Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer
M&T Bank Corp Has $34.43 Million Position in Bristol Myers Squibb Company $BMY
Patrick Mauro Investment Advisor INC. Purchases Shares of 56,125 Bristol Myers Squibb Company $BMY - Markets Daily
Prudential PLC Acquires 36,159 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY is Independent Franchise Partners LLP's 2nd Largest Position
Bristol Myers Squibb Company $BMY Shares Sold by Dodge & Cox
iSAM Funds UK Ltd Makes New $2.36 Million Investment in Bristol Myers Squibb Company $BMY - Stock Observer
Cadence Bank Increases Stock Holdings in Bristol Myers Squibb Company $BMY
Patrick Mauro Investment Advisor INC. Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Brokerages - Stock Observer
Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma
Bristol Myers Squibb Company $BMY Shares Purchased by Te Ahumairangi Investment Management Ltd - Stock Observer
Opdualag (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Bristol Myers Squibb Company $BMY Shares Sold by Martingale Asset Management L P
143,691 Shares in Bristol Myers Squibb Company $BMY Acquired by Entropy Technologies LP
Martingale Asset Management L P Has $21.75 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Bokf Na Boosts Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Employees Retirement System of Texas - Stock Observer
Quadrature Capital Ltd Purchases Shares of 532,436 Bristol Myers Squibb Company $BMY - Daily Political
Mackenzie Financial Corp Acquires 149,701 Shares of Bristol Myers Squibb Company $BMY - Daily Political
A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Volatility
Merck's WELIREG Kidney Cancer Trials Deepen Oncology Growth Story
Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight
Bristol Myers Squibb Company $BMY Shares Purchased by Franklin Resources Inc. - Stock Observer
Piper Sandler Sees Path to Growth for Bristol-Myers Squibb Company (BMY) After Eliquis Patent Expiry
How Investors May Respond To Bristol Myers (BMY) Mezigdomide Successor-2 Data And New Sotyktu Approval
Richard Bernstein Advisors LLC Lowers Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Capital Group Private Client Services Inc.
How big business is rewriting the U.S. sustainability story
BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma
UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms
LGT Fund Management Co Ltd. Has $372,000 Stock Position in Bristol Myers Squibb Company $BMY
Abecma (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Bristol Myers Squibb Pipeline Update With New TYK2 And CELMoD Milestones
Bristol-Myers Squibb Readies New Growth Drivers In Immunology And Cancer
Banque Cantonale Vaudoise Acquires 26,347 Shares of Bristol Myers Squibb Company $BMY
Van ECK Associates Corp Acquires 3,982,439 Shares of Bristol Myers Squibb Company $BMY - Daily Political
LGT Fund Management Co Ltd. Has $372,000 Holdings in Bristol Myers Squibb Company $BMY - Daily Political
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
Health: Bristol's drug enhances survival rates in late-stage blood cancer trial
Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight
Swiss National Bank Has $264.57 Million Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Korea Investment CORP
Schroder Investment Management Group Has $548.82 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Blair William & Co. IL Lowers Holdings in Bristol Myers Squibb Company $BMY
BristolMyers News
Best ETF for Your 2026 Portfolio: Vanguard S&P 500 VOO ETF, SPY ETF, QQQ ETF
South Africa’s PPI Falls to 2.2%: the Producer Price Index explained, what is PPI and how to calculate it?
Gold Bear Market Hits South Africa: Time to Buy the Dip on Gold Before the Next Rally?
NVIDIA SWOT analysis 2026: Why NVDA stock is steady recently, time to buy the dip?
AI stock outlook: Micron Technology stock falls over 4%, what factors could influence MU stock by 2026?
ZAR/USD smashed to fresh lows: How to start forex trading as a beginner in South Africa?
Weekly Forex Forecast: EUR/USD Eyes 1.16 Support as AUD/USD Rallies and USD/JPY Tests 160.00
Tesla (NASDAQ:TSLA) stock is trading down: Can I invest in Tesla from South Africa?
Latest news
Show moreFederal Reserve Independence Under Pressure: Navigating Political and Regulatory Challenges
Berkshire Hathaway Deepens Japanese Investment with Strategic Stake in Tokio Marine
Global Markets Surge on Trump's Hints of De-escalation with Iran; Key Issues Remain
Goldman Sachs Raises Oil Price Forecast Amidst Hormuz Strait Disruption and Global Supply Fragility
